Skip to main content

CORRECTION article

Front. Bioeng. Biotechnol., 10 October 2022
Sec. Industrial Biotechnology
Volume 10 - 2022 | https://doi.org/10.3389/fbioe.2022.1048797

Corrigendum: Large-scale preparation of highly stable recombinant human acidic fibroblast growth factor in Escherichia coli BL21(DE3) plysS strain

This article is a correction to:

  1. Large-Scale Preparation of Highly Stable Recombinant Human Acidic Fibroblast Growth Factor in Escherichia coli BL21(DE3) plysS Strain

    1. Read original article
Bingjie Yu,&#x;Bingjie Yu1,2†Wenzhe Sun&#x;Wenzhe Sun1†Zhen Huang&#x;Zhen Huang1†Gang SunGang Sun1Le LiLe Li1Jiawei GuJiawei Gu1Mengying ZhengMengying Zheng1Xiaokun Li,Xiaokun Li1,3ChangJu ChunChangJu Chun4Qi Hui, Qi Hui1,3*Xiaojie Wang, Xiaojie Wang1,3*
  • 1Wenzhou Medical University, Chashan University Park, Wenzhou, China
  • 2College of Pharmacy, Chonnam National University, Gwangju, South Korea
  • 3Engineering Laboratory of Zhejiang Province for Pharmaceutical Development of Growth Factors, Biomedical Collaborative Innovation Center of Wenzhou, Wenzhou, China
  • 4Research Institute of Pharmaceutical Sciences, College of Pharmacy, Chonnam National University, Gwangju, South Korea

A Corrigendum on
Large-scale preparation of highly stable recombinant human acidic fibroblast growth factor in Escherichia coli BL21(DE3) plysS strain

by Yu B, Sun W, Huang Z, Sun G, Li L, Gu J, Zheng M, Li X, Chun C, Hui Q and Wang X (2021). Front. Bioeng. Biotechnol. 9:641505. doi: 10.3389/fbioe.2021.641505

In the published article, an author name was incorrectly written as Bingjieu Yu. The correct spelling is “Bingjie Yu”.

Furthermore, there was an error regarding the affiliation for Bingjie Yu. Beyond having affiliation 1, they should also have affiliation 2 (added here), “College of Pharmacy, Chonnam National University, Gwangju, South Korea.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: rhaFGF135, Escherichia coli BL21(DE3)pLysS, fermentation, purification, wound healing

Citation: Yu B, Sun W, Huang Z, Sun G, Li L, Gu J, Zheng M, Li X, Chun C, Hui Q and Wang X (2022) Corrigendum: Large-scale preparation of highly stable recombinant human acidic fibroblast growth factor in Escherichia coli BL21(DE3) plysS strain. Front. Bioeng. Biotechnol. 10:1048797. doi: 10.3389/fbioe.2022.1048797

Received: 20 September 2022; Accepted: 22 September 2022;
Published: 10 October 2022.

Copyright © 2022 Yu, Sun, Huang, Sun, Li, Gu, Zheng, Li, Chun, Hui and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Xiaojie Wang, wangxiaojie1972@126.com; Qi Hui, huiqi1976@163.com

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.